Express Scripts Holding Co. (NASDAQ:ESRX) is now eyeing the $37 billion US cancer market, after the company forced drug makers to reduce the the cost of Hepatitis C drugs and leading to current and future savings of billions of dollars.
After Saving Billions From Hepatitis C Price Wars, Express Scripts (ESRX) Goes After Cancer Drugs
Bidness etc. - 23 Jan 2015 23:26
Express Scripts Holding Co. (NASDAQ:ESRX) is now eyeing the $37 billion US cancer market, after the company forced drug makers to reduce the the cost of Hepatitis C drugs and leading to current and future savings of billions of dollars.
Share this Article
Comment on this Article
Recommended
Please to comment